Skip to main content

Minister questioned on Government's approach to commercial genomics

12 June 2020

The Science and Technology Committee takes evidence for its inquiries on Commercial Genomic and UK science, research and technology capability and influence in global disease outbreaks.

Witnesses

Wednesday 17 June, virtual meeting

At 2.30pm

  • Dr Tara Clancy, Council Member, Nuffield Council on Bioethics

At 3.00pm

  • Graeme Tunbridge, Director of the Devices Division, Medicines and Healthcare products Regulatory Agency (MHRA)

At 3.30pm

  • Lord Bethell of Romford, Minister for Innovation, Department of Health and Social Care
  • Professor Sir Mark Caulfield, Chief Scientist, Genomics England
  • Graeme Tunbridge, Director of the Devices Division, Medicines and Healthcare products Regulatory Agency (MHRA)

The first half of this session will scrutinise both the regulation and ethical aspects of direct-to-consumer genomic testing. The Committee will then question the Minister for Innovation at the Department of Health and Social Care, to discuss the Government's approach to commercial genomics.

The Committee will also question the Minister in relation to its UK science, research and technology capability and influence in global disease outbreaks inquiry, regarding the ‘test and trace' system adopted to deal with COVID-19.

Further information

Image: Parliamentary copyright